Back to search

Article

Clinical performance and utility of a noninvasive urine-based methylation biomarker—TWIST1/Vimentin to detect urothelial carcinoma of the bladder

2023-11-06

Abstract excerpt

Traditional clinical modalities for diagnosing bladder urothelial carcinoma (BUC) remain limited due to their invasive nature, significant costs, discomfort associated with cystoscopy, and low sensitivity to urine cytology. Therefore, there is an urgent need to identify highly sensitive, specific, and noninvasive biomarkers for the early detection of this neoplasm. Hypermethylated TWIST 1 /Vimentin promoter may be...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
f9bc58e9-b373-50ff-8f1f-88e09898bb8e
DOI
10.21203/rs.3.rs-3526502/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Clinical performance and utility of a noninvasive urine-based methylation biomarker—TWIST1/Vimentin to detect urothelial carcinoma of the bladderDOI 10.21203/rs.3.rs-3526502/v1
Select a neighboring publication to make it the new centre.